Abstract
A lack of clinical trials devoted specifically to treatment protocols in minority groups and diverse individuals with skin of color (SOC) exists. Treatment decisions often vary based on patient cultural preferences and have differing efficacies based on skin type. As such, it is important to evaluate the diversity of participants being included in dermatology clinical trials.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
